enzalutamide,talazoparib
astellas,pfizer
['talapro,2', 'talazo', 'enzalu', 'crpc', 'talapro2', 'enzalutamide']
patient-reported outcomes among men receiving talazoparib + enzalutamide vs pbo + enza as first-line treatment for #mcrpc: results from a phase 3 study #talapro2. presented by . #asco23 written coverage by &gt; 
Largest global online community of #urological medical professionals & patients. #bladdercancer #menshealth #prostatecancer #kidneycancer #Urology